https://de.marketscreener.com/kurs/aktie/INCYTE-CORPORATION-9675/news/Incyte-meldet-Zulassung-von-Pemazyre-Pemigatinib-durch-die-Europaische-Kommission-zur-Behandl-32842446/?utm_source=telegram&utm_medium=social&utm_campaign=share